Clinical Characteristics and Outcomes in NSCLC Patients Associated with Very High PD-L1 Expression

被引：0
|
作者：
Mcloughlin, E. [1 ]
Hanson, L. [2 ]
Moore, M. [3 ]
Horton, B. [4 ]
Gentzler, R. [1 ]
Hall, R. [1 ]
机构：
[1] Univ Virginia, Div Hematol Oncol, Charlottesville, VA USA
[2] Univ Virginia, Med, Charlottesville, AL USA
[3] Univ Virginia, Sch Med, Charlottesville, AL USA
[4] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Div Translat Res & Appl Stat, Charlottesville, AL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Non-Small Cell Lung Cancer; metastatic;
D O I：
10.1016/j.jtho.2019.08.1395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-52
引用
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [21] PD-L1 expression in NSCLC and biopsy size
    Kern, I.
    Kovacevic, M.
    Janzic, U.
    Cufer, T.
    VIRCHOWS ARCHIV, 2016, 469 : S127 - S127
  • [22] ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients
    Chang, Gee-Chen
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Huang, Yen-Hsiang
    Su, Kang-Yi
    Yu, Sung-Liang
    Tseng, Jeng-Sen
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma
    Slomka, Jeremy
    Berthou, Hugo
    Mansuet-Lupo, Audrey
    Blons, Helene
    Fabre, Elizabeth
    Lerner, Ivan
    Rance, Bastien
    Alifano, Marco
    Chapron, Jeanne
    Birsen, Gary
    Gibault, Laure
    Arrondeau, Jennifer
    Leroy, Karen
    Wislez, Marie
    PLOS ONE, 2024, 19 (11):
  • [24] Outcomes to first-line pembrolizumab in patients with advanced NSCLC and high PD-L1 expression: A Spanish multicentric study
    Piedra, A.
    Recio, S. Martinez
    Gonzalez, A. Hernandez
    Bueno, M. T. Moran
    Arriola, E.
    Recuero-Borau, J.
    Dols, M. Cobo
    Gonzalez, P. Cordeiro
    Martinez, J. Mosquera
    Garcia-Campelo, M. R.
    Blanco, A. Calles
    Alvarez, R. M.
    Garcia, M. Zapata
    Casado, M. D. Isla
    Perez, A. Callejo
    Gomez, P. Iranzo
    Joaquin, A. Barba
    Sullivan, I. G.
    Felip, E.
    Majem, M.
    ANNALS OF ONCOLOGY, 2023, 34
  • [25] Comparison of Clinical Outcomes of Patients With Advanced NSCLC In Clinical Trials and in the Real World Received PD-1/PD-L1 Inhibitor
    Wang, H.
    Wei, C.
    Zhang, G. W.
    Zhang, M.
    Yan, X.
    Zhang, X.
    Niu, Y. Y.
    Yang, J.
    Ma, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1017 - S1017
  • [26] HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC
    Liu, Xiaomei
    Wang, Yuxi
    Zhang, Rong
    Jin, Ting
    Qu, Liangliang
    Jin, Qianwen
    Zheng, Jiasu
    Sun, Jiaqi
    Wu, Ziqing
    Wang, Linxi
    Liu, Tianxu
    Zhang, Yinxu
    Meng, Xiao
    Wang, Ying
    Wei, Ning
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [27] High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms
    Sampaio, Leticia Rodrigues
    Viana, Mateus de Aguiar
    de Oliveira, Vanessa Silva
    Ferreira, Bruna Vitoriano
    Melo, Mayara Magna Lima
    de Oliveira, Roberta Taiane Germano
    Borges, Daniela de Paula
    Magalha, Silvia Maria Meira
    Pinheiro, Ronald F.
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (02) : 146 - 152
  • [28] PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Bazan, Viviana
    Natoli, Clara
    Rizzo, Sergio
    Galvano, Antonio
    Listi, Angela
    Cicero, Giuseppe
    Rolfo, Christian
    Santini, Daniele
    Russo, Antonio
    ONCOTARGET, 2016, 7 (15) : 19738 - 19747
  • [29] PD-L1 Expression as Predictive Biomarker in Patients with NSCLC: A Pooled Analysis
    Passiglia, Francesco
    Bronte, Giuseppe
    Rizzo, Sergio
    Galvano, Antonio
    Sortino, Giovanni
    Musso, Emmanuela
    Listi, Angela
    Barraco, Nadia
    Castiglia, Marta
    Calo, Valentina
    Bazan, Viviana
    Cicero, Giuseppe
    Rolfo, Christian
    Russo, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S232 - S233
  • [30] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    CANCERS, 2019, 11 (06):
12345